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Precision genome editing tools are invaluable for biology, 
medicine and agriculture. With these tools we can deter-
mine the genetic basis underlying biological traits and pro-
cesses, and then modify the genome of crops and livestock, 
model organisms, and even of patients, for phenotypic im-
provement, disease modeling and treatment. Site-specific 
nucleases provide a powerful and effective approach for 
precise genome editing in organisms [1]. Two types      
of site-specific nucleases, namely zinc finger nucleases 
(ZFNs) and transcription activator-like effector nucleases 
(TALENs), have already been widely used for genome en-
gineering. Both of them are composed of two functional 
modules: the DNA binding domain that is programmable 
for specific DNA sequence binding, and the Fok1 nuclease 
domain that can induce double strand breaks. By non-  
homologous end joining repair, the double strand breaks at 
target sites can therefore produce sequence insertions and 
deletions (indels). Recently, a new type of site-specific nu-
cleases, the CRISPR (clustered regularly interspaced short 
palindromic repeats)/Cas (CRISPR- associated) system, has 
emerged and raised a revolution in the genomics field. 
The CRISPR/Cas system is an acquired immune system 
of many bacteria and archaea, which can identify the alien 
plasmids or phages and cut them by the Cas protein. Thus 
by inserting a plasmid containing Cas genes and specifically 
designed CRISPRs, an organism’s genome can be cut at any 
desired location. Following this idea, the CRISPR/Cas sys-
tem was first used for genome editing via specific gene si-
lencing in 2012. In 2013, this system was first adapted for 
genome editing in mammalian cells, which laid the basis for 
the widely application of this technology [2,3]. In contrast 
to ZFN and TALEN, gene targeting of the CRISPR/Cas 
system is mediated by a small RNA, which make it very 
easy to design and achieve multiplex genome editing. Till 
now, the CRISPR/Cas system-mediated gene targeting has 
been successfully applied in many kinds of species, includ-
ing plants, flies, zebrafish and rodents [4]. Notably, multiple 
gene knockout mice and rats, which may need more than 
two years to construct by conventional embryonic stem 
cell-based method, could be simultaneously generated in 
nearly one month in one-step by zygote injection of Cas9 
RNA and guide RNAs. By the zygote-injection approach, 
the CRISPR/Cas system has also produced biallelic knock-
out pigs, demonstrating the feasibility of this technique in 
large animals [5]. Recently, gene targeting in non-human 
primates has also been achieved for the first time through 
the CRISPR/Cas system [6]. These findings revolutionize 
the generation of gene-targeting models, which now could 
be achieved in any species with the help of the CRISPR/Cas 
system. 
Besides gene mutations, the CRISPR/Cas system also 
has other promising applications in genome manipulation 
[4]. The RNA-guided properties enable the CRISPR/Cas 
system to produce genome-wide genetic mutations rather 
than to modulate individual genes. Several studies using 
lentivirus-based guide RNA libraries have demonstrated the 
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feasibility to use the CRISPR/Cas system for high- 
throughput genetic screening in human cells. The CRISPR/ 
Cas system modulate the genome through forming a three- 
component-complex: the Cas9 protein, the guide RNA and 
the double strand DNA. So the application could be repur-
posed by modulating the Cas9 function without altering its 
three-component-complex forming ability. By mutating the 
nuclease function and fusing the transcription activation or 
repression domains to Cas9 protein, several groups have 
successfully activated or silenced endogenous gene expres-
sion with the CRISPR/Cas system, suggesting the applica-
tion potential in gene expression modulation. Another 
promising potential application of the CRISPR/Cas system 
is to modify the epigenome. Genome editing technologies 
like gene knockout can provide direct links between geno-
types and phenotypes, and are widely used and play im-
portant roles in genetics and functional genomics studies. 
Thus it is interesting to develop targeted epigenetic editing 
tools similar to gene knock-out or knock-in. By fusing the 
endonuclease-mutant Cas9 with an epigenetic modulation 
domain, such as DNA methylation domain, the CRISPR/ 
Cas system would be repurposed to modify the epigenetic 
modifications of targeted regions. It is foreseeable that such 
epigenetic editing tools will provide a new approach for 
epigenetics research. Altogether, the CRISPR/Cas system 
hold great potential to be repurposed to implement more 
functions including but not limited to above mentioned 
ones.  
However, a major concern of the CRISPR/Cas system 
has been raised on the potential off-target effects. Several 
studies revealed that sequence mismatches distal from the 
protospacer adjacent motif (PAM) at the 5′ end of guide 
RNAs could be tolerated therefore to induce off-target mu-
tagenesis even with frequencies comparable to those ob-
served at the intended on-target sites [7]. In order to reduce 
or even eliminate the off-target effects, different attempts 
have been made. One approach is to use a mutant form of 
Cas9 protein, the Cas9 nickase, rather than to use Cas9 en-
donuclease [8]. These Cas9 mutants simply introduce the 
offset gap instead of the DNA double strand break, there-
fore could reduce off-target effects. Studies also showed 
that the guide RNAs containing 17 or 18 nucleotides have 
the similar target binding ability (or even higher) compared 
with the full length guide RNAs, yet their off-target effects 
were greatly reduced, suggesting truncated guide RNAs 
may be adopted to avoid off-target effects. The off-target 
effects would be further reduced by combining the truncated 
guide RNAs with the Cas9 nickase [8]. 
In summary, the CRISPR/Cas system provides a new 
important tool for genome engineering. The easy program-
mability and high efficiency make it being successfully used 
in many kinds of species, ranging from plants, flies, fish, 
rodents, farm animals, to monkeys and human. Besides ge-
nome editing, the CRISPR/Cas system can also be easily 
repurposed to implement versatile functions for many other 
biological purpose. By further development and improve-
ment of the system, we believe that the CRISPR/Cas system 
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